BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 13, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 18, 2018
View Archived Issues
FDA accepts IND application for BIVV-003 as treatment for sickle cell disease
Read More
Eisai reviews key milestones of fourth quarter of fiscal 2017
Read More
G1 Therapeutics initiates phase I study of G1T48 in ER-positive, HER-negative advanced breast cancer
Read More
MedImmune studies MEDI-9447 combination therapies for advanced NSCLC
Read More
Bayer initiates phase II/III study of rogaratinib in FGFR-positive advanced urothelial carcinoma
Read More
SCGA gene expression seen after vector delivery in limb girdle muscular dystrophy type 2D patients
Read More
Primary endpoint met in phase III study of Lyrica oral solution CV in pediatric epilepsy
Read More
Rocket Pharmaceuticals partners with Stanford University School of Medicine on gene therapies
Read More
BeiGene initiates phase III study of pamiparib in ovarian cancer
Read More
Takeda reflects on active fourth quarter of fiscal 2017
Read More
IND-enabling studies initiated for Bicycle Therapeutics' BT-5528
Read More
Sumitomo Dainippon Pharma presents preclinical results for DSP-0692 in cancer
Read More
Profectus Biosciences and Medisun Holdings team to launch ProMed BioSciences
Read More
FDA approves Aimovig for prevention of migraine
Read More
Merck KGaA and Washington University in St. Louis to study gut microbiome for malnourishment
Read More
Pharmazz presents promising interim analysis of phase II data for PMZ-2010
Read More
Janssen discontinues development of atabecestat for late-onset preclinical stage Alzheimer's
Read More
MET inhibitor OMO-1 shows promising preclinical antitumoral activity
Read More
IDAC Theranostics and Keio University present apoptosis inducers
Read More
Qingdao Marine Biomedical Research Institute patents ROS-production inhibitors
Read More
Beijing Konruns Pharmaceutical divulges UFO and VEGFR-2 inhibitors
Read More
CRISPR Therapeutics designs new method for generating BCMA-targeted CAR-T cells
Read More
Damian Pharma discloses CYP11B2 inhibitors
Read More
Daewoong Pharmaceutical presents TNF-alpha production inhibitors
Read More